FindTrial
Sign In

Novel Safe Transport Medium and Rapid RNA Extraction Method for COVID-19

Evaluation of a Novel Safe Transport Medium for Transportation of Sample and a Rapid Solution-Based RNA Extraction Method for Laboratory Diagnosis of COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027103
Enrollment
100
Registered
2020-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

BioEra Life Sciences Pvt Ltd Pune
Lead Sponsor
Dean BJ Medical College Pune
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted in COVID-19 wards

Exclusion criteria

Exclusion criteria: Patients on Ventilator

Design outcomes

Primary

MeasureTime frame
Safe Transport Medium for Transportation of Sample is effective and safe Rapid Solution-Based RNA Extraction Method for Laboratory Diagnosis of COVID-19 is usefulTimepoint: 15 days after the commencement of the study 1 month after commencement of study that is the end of the study—

Secondary

MeasureTime frame
Safe transport medium keeps the virus stable at room temperature and RNA extracted is giving same Ct values as compared to column based and magnetic bead based systemsTimepoint: 15 days after the commencement of the study 1 month after commencement of study that is the end of the study—

Countries

India

Contacts

Public ContactDr Rajesh Karyakarte

BJ Medical College, Pune

karyakarte@hotmail.com9922402502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026